Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Breast Cancer Research and Treatment|November 4, 2005
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancerM Venturini, C Bighin, S Monfardini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Doxifluridine and leucovorin: an oral treatment combination in advanced colorectal cancerE Bajetta, M Colleoni, M Di Bartolomeo, et al.British Journal of Cancer|January 8, 2004
Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)F Cappuzzo, S Bartolini, G L Ceresoli, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patientsC Tibaldi, E Giovannetti, M Tiseo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Consequences of targeted treatments for second-line therapyE De Maio, C Tibaldi, A D'Incecco, et al.Journal of Clinical Pathology|October 29, 2009
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancerM Varella-Garcia, J Diebold, D A Eberhard, et al.Lung Cancer (Amsterdam, Netherlands)|April 25, 2006
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapyF Cappuzzo, S Novello, F De Marinis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant diseaseE Bajetta, A Di Leo, L Biganzoli, et al.Lung Cancer (Amsterdam, Netherlands)|May 30, 2023
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinomaF T Gallina, D Marinelli, E Melis, et al.British Journal of Cancer|January 26, 2013
HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patientsV Martin, L Landi, F Molinari, et al.Pageof 6